Research summary, original research, 2018

Three-Dimensional Echocardiographic Guidance of Right Heart Catheterization Decreases Radiation Exposure in Atrial Septal Defect Closures

Jone PN, Zablah JE, Burkett DA, Schäfer M, Wilson N, Morgan GJ, et al.. Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography. 2018

Read the original paper

In plain language

In 22 children having atrial septal defect closure, using 3D transesophageal echo to guide right heart catheterization cut fluoroscopy time by 54% and patient radiation by 78% versus historical controls. Staff dose was not measured, though less fluoroscopy likely lowers it.

At a glance

Type of study
Original research, Retrospective cohort study
Who was studied
Patients
Size
n = 66 patients (22 with 3D TEE guidance, 44 historical controls)
Summary based on
the abstract

What it found

  • 3D transesophageal echocardiography (TEE) guidance of right heart catheterization in atrial septal defect (ASD) closure reduced total fluoroscopy time and radiation dose compared with historical controls.

    Key figures: 54% reduction in fluoroscopy time; 78% radiation reduction

  • Fluoroscopy time for the right heart catheterization step under 3D TEE guidance was almost zero.

    Key figures: mean 0.06 ± 0.23 min

  • RHC time decreased along the learning curve.

    Key figures: r = -0.63, P < .01

  • No significant differences in RHC time or total procedural time versus controls.

Limits to keep in mind

Small single-series study with historical controls, so groups may differ in ways other than guidance method. Only patient dose and fluoroscopy time were measured; staff dose was not assessed.

How this summary was made

ORSIF prepared this summary with AI assistance from the abstract of the paper. A program then checked that the passage supporting each finding appears word for word in that source. A person has not yet reviewed each summary, so read the original before relying on a number. ORSIF summarizes research and does not endorse any product or company. Report a problem with this summary.

Prepared November 3, 2026.